New study on Hepatitis C drug treatment in vivo and in vitro

An interdisciplinary effort by mathematical modelers, clinicians and virologists has revealed that daclatasvir has two main modes of action against HCV and also yields a more accurate new estimate of the HCV half-life.

Fuente : http://www.eurekalert.org/pub_releases/2013-02/luh…